Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Inventory (2018 - 2025)

TELA Bio (TELA) has 8 years of Inventory data on record, last reported at $11.6 million in Q3 2025.

  • For Q3 2025, Inventory fell 15.01% year-over-year to $11.6 million; the TTM value through Sep 2025 reached $11.6 million, down 15.01%, while the annual FY2024 figure was $12.8 million, 2.89% down from the prior year.
  • Inventory reached $11.6 million in Q3 2025 per TELA's latest filing, up from $11.4 million in the prior quarter.
  • Across five years, Inventory topped out at $15.1 million in Q1 2023 and bottomed at $4.5 million in Q2 2021.
  • Average Inventory over 5 years is $11.3 million, with a median of $12.1 million recorded in 2022.
  • Peak YoY movement for Inventory: skyrocketed 128.54% in 2022, then fell 15.01% in 2025.
  • A 5-year view of Inventory shows it stood at $7.7 million in 2021, then soared by 53.98% to $11.8 million in 2022, then grew by 11.62% to $13.2 million in 2023, then dropped by 2.89% to $12.8 million in 2024, then dropped by 9.57% to $11.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Inventory were $11.6 million in Q3 2025, $11.4 million in Q2 2025, and $13.5 million in Q1 2025.